Herz

Papers
(The TQCC of Herz is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Heart and brain interactions27
Vagal stimulation in heart failure24
Evaluation of the relationship between COVID-19 pneumonia severity and pulmonary artery diameter measurement19
Comorbidities in heart failure with preserved ejection fraction18
The future of heart failure with preserved ejection fraction14
Myocardial involvement in coronavirus disease 1914
Gender and career in cardiology—a cross-sectional study12
Luftverschmutzung und Herz-Kreislauf-Erkrankungen11
The COVID-19 pandemic in China: from dynamic zero-COVID to current policy10
Role of iron homeostasis in the heart10
Valvular heart disease in patients with chronic kidney disease10
Medikamentöse Sekundärprävention bei Patienten mit peripherer arterieller Verschlusskrankheit10
Role of IL-9, IL-2RA, and IL-2RB genetic polymorphisms in coronary heart disease10
Clinical review of sick sinus syndrome and atrial fibrillation9
Mapping atrial fibrillation9
Atrial remodeling and atrial fibrillation recurrence after catheter ablation8
ESC-Leitlinien 2020 zum Vorhofflimmern8
Favorable electrocardiographic changes after substantial weight loss in patients with morbid obesity8
Mind and body interventions in cardiology8
Comparison of outcomes between single long stent and overlapping stents: a meta-analysis of the literature8
Management kardiovaskulärer Erkrankungen bei Patienten mit Diabetes7
ESC-Leitlinie 2020: akutes Koronarsyndrom ohne persistierende ST-Strecken-Hebungen7
ESC-Leitlinie 2020 zur Behandlung von Erwachsenen mit angeborenem Herzfehler (ACHD)7
Herzinsuffizienzleitlinien 2021 der ESC7
COVID-19-Pandemie6
Current status of antithrombotic therapy and in-hospital outcomes in patients with atrial fibrillation undergoing percutaneous coronary intervention in Germany6
ESC-Leitlinie 2022 onkologische Kardiologie6
ESC-Leitlinie Sportkardiologie 20205
Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic5
Infarktbedingter kardiogener Schock5
Associations between genetic variations in microRNA and myocardial infarction susceptibility: a meta-analysis and systematic review5
Current devices and interventions in mitral regurgitation5
First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study4
Diagnostik und Therapie der Lungenembolie4
Die ESC zu COVID-19 – keine Leitlinie, aber ein lernender Leitfaden4
Patent foramen ovale—When to close and how?4
Relationship between myocardial bridging and fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy: the HCM-MB study4
ERC-Leitlinien 2021 zur kardiopulmonalen Reanimation4
Increased cardiovascular risk in patients with chronic kidney disease4
ESC-Leitlinien 2021 zur Schrittmacher- und Resynchronisationstherapie4
2022 ESC/ERS-Leitlinien zur Diagnostik und Therapie der pulmonalen Hypertonie4
Endocardial left ventricular pacing4
Lärmbelästigung in der deutschen Allgemeinbevölkerung4
Correlation between decreased plasma miR-29a and vascular endothelial injury induced by hyperlipidemia4
Risk stratification for sudden cardiac death in patients with heart failure4
New therapeutic approaches for the treatment of hypertriglyceridemia3
Digital health solutions in the screening of subclinical atrial fibrillation3
Heart failure in advanced chronic kidney disease: treatment rationale3
Diagnose und Behandlung der kardialen Amyloidose3
Bifurkationsläsionen3
Neglected cardiovascular diseases and their significance in the Global North3
Statinintoleranz und statinassoziierte Muskelschmerzen3
Catheter-directed therapy in pulmonary embolism3
Relationship between platelet mass index and postoperative atrial fibrillation after elective coronary artery bypass surgery: a retrospective study3
Association between MTHFR C677T polymorphism and risk of coronary artery disease in the Chinese population: meta-analysis3
Estimates of excess mortality during the COVID-19 pandemic strongly depend on subjective methodological choices3
RAAS inhibition and beyond—cardiovascular medications in patients at risk of or affected by COVID-193
Environmental factors and their impact on the COVID-19 pandemic3
Cardiovascular disease in patients with chronic kidney disease3
Impact of atrial flow regulator (AFR) implantation on 12-month mortality in heart failure3
Cardiac amyloidosis—interdisciplinary approach to diagnosis and therapy3
Neue ESC-Leitlinien 2021 zur Prävention von kardiovaskulären Erkrankungen3
Echocardiographic assessment in cardiogenic shock3
Diagnostic role of echocardiography for patients with heart failure symptoms and preserved left ventricular ejection fraction3
Herz-Kreislauf-Erkrankungen und COVID-193
Obesity paradox in pulmonary hypertension due to left ventricular systolic dysfunction3
Herzinsuffizienz: Leitlinien-Update der ESC 20233
Clinical significance of glycated hemoglobin in acute coronary syndrome patients from the CCC-ACS project3
A practical approach for the treatment of post-COVID symptoms2
Effects of TCFA on stent neointimal coverage at 9 months after EXCEL drug-eluting stent implantation assessed by OCT2
Is coronary artery tortuosity a predisposing factor for drug-eluting stent restenosis?2
Non-transvenous ICD therapy: current status and beyond2
Survey of clinical practice pattern in Germany’s certified chest pain units2
Prevalence of atrial fibrillation2
Serum heparanase levels and left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation2
Computed tomography to guide transcatheter aortic valve implantation2
Supraventricular arrhythmia in mitral valve prolapse2
Safety and feasibility of same-day discharge following catheter ablation of atrial fibrillation: what is known and what needs to be explored?2
Cardiac proteostasis in obesity and cardiovascular disease2
Lipoproteinapherese2
Personalisierte Behandlungskonzepte bei arterieller Hypertonie2
Prävention des plötzlichen Herztods2
Rhythmologische und metabolische Kontrolle2
Management strategies in heart failure with preserved ejection fraction2
Refined risk stratification, current treatment, and new therapeutic approaches in pulmonary arterial hypertension2
Diabetes, heart failure, and myocardial revascularization: Is there a new message from the ISCHEMIA trial?2
Assessment of proarrhythmic ventricular electrophysiological remodeling in patients with rheumatoid arthritis2
Morphologische und funktionelle Diagnostik der koronaren Herzkrankheit mittels Computertomographie2
Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI2
ESC-Leitlinien 2023 zum Management der Endokarditis2
Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes2
On the gap between objective and perceived risks of COVID-192
Die neue ESC-Leitlinie zum Management ventrikulärer Tachyarrhythmien2
Gesättigte Fettsäuren und kardiovaskuläres Risiko2
Aorten- und Herzklappenerkrankungen, Kardiomyopathien und Herzinsuffizienz in der Schwangerschaft2
Peripoperative Mortalität nach ICD-Implantation2
0.031739950180054